Important and emerging β-lactamase-mediated resistances in hospital- based pathogens: The Amp C enzymes

Diagnostic Microbiology and Infectious Disease

Volumn 31, Issue 3, 1998, Pages 461-466

  Jones, Ronald N ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; CEFPIROME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; OXACILLIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL INFECTION; CONFERENCE PAPER; DRUG POTENCY; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; NONHUMAN; PRIORITY JOURNAL;

BACTERIAL PROTEINS; BETA-LACTAMASES; BETA-LACTAMS; CEPHALOSPORINS; CROSS INFECTION; DRUG RESISTANCE, MICROBIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; ENZYME INDUCTION; HUMANS;

EID: 0031800337     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(98)00029-7     Document Type: Conference Paper

References (28)

1. Ambler R.P. The structure of β-lactamases. Philos Trans R Soc Lond Ser B. 289:1980;321-331.
2. Ballow C.H., Schentag J.J. Trends in antimicrobial utilization and bacterial resistance report of the National Resistance Surveillance Group . Diagn Microbiol Infect Dis. 15:(suppl):1992;37S-42S.
3. Burwen D.R., Banerjee S.N., Gaynes R.P. Ceftazidime resistance among selected nosocomial Gram-negative bacilli in the United States. J Infect Dis. 170:1994;1622-1625.
4. Bush K. Characterization of β-lactamases Groups 1, 2a, 2b and 2c . Antimicrob Agents Chemother. 33:1989;264-270.
5. Bush K., Jacoby G.A., Medeiros A.A. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother. 39:1995;1211-1233.
6. Curtis N.A.C., Eisenstadt R.L., Rudd C., White A.J. Type 1 β-lactamases of Gram-negative bacteria and resistance to β-lactam antibiotics. J Antimicrob Chemother. 17:1986;51-61.
7. Dietz H, Pfeiele D, Wiedemann B (1997) The signal molecule for β-lactamase induction in Enterobacter cloacae is the anhydromuramy-pentapeptide. Antimicrob Agents Chemother 41:2113-2120. Farmer TH, Reading C (1987) Induction of the β-lactamases of a strain of Pseudomonas aeruginosa, Morganella morganii and Enterobacter cloacae. J Antimicrob Chemother 19:401-408.
8. Dietz H, Pfeiele D, Wiedemann B (1997) The signal molecule for β-lactamase induction in Enterobacter cloacae is the anhydromuramy-pentapeptide. Antimicrob Agents Chemother 41:2113-2120. Farmer TH, Reading C (1987) Induction of the β-lactamases of a strain of Pseudomonas aeruginosa, Morganella morganii and Enterobacter cloacae. J Antimicrob Chemother 19:401-408.
9. Fung-Tomc J.C., Gradelski E., Huckzo E., Dougherty T.J., Kessler R.E., Bonner D.P. Differences in the resistant variants of Enterobacter cloacae selected by extended-spectrum cephalosporins. Antimicrob Agents Chemother. 40:1996;1289-1293.
10. Glauser M. Empiric therapy of bacterial infections in patients with severe neutropenia. Diagn Microbiol Infect Dis. 31:1998;467-472.
11. Goodell E.W. Recycling of murein by Escherichia coli. J Bacteriol. 163:1985;305-310.
12. Hancock R.E.W., Bellido F. Factors involved in the enhanced efficacy against Gram-negative bacteria of fourth-generation cephalosporins. J Antimicrob Chemother. 29:(suppl A):1992;1-6.
13. Johnson M.P., Ramphal R. β-lactam-resistant Enterobacter bacteremia in febrile neutropenic patients receiving monotherapy. J Infect Dis. 162:1990;981-983.
14. Jones R.N. The antimicrobial activity of cefotaxime comparative multinational hospital isolate surveys covering 15 years . Infection. 22:(suppl 3):1994;S152-S160.
15. Jones R.N. Impact of changing pathogens and antimicrobial susceptibility patterns in the treatment of serious infections in hospitalized patients. Am J Med. 100:(suppl 6A):1996;3S-12S.
16. Jones R.N., Pfaller M.A., Allen S.D., Gerlach E.H., Fuchs P.C., Aldridge K.E. Antimicrobial activity of cefpirome. An update compared to five third-generation cephalosporins against nearly 6,000 recent clinical isolates from five medical centers. Diagn Microbiol Infect Dis. 14:1991;361-364.
17. Jones R.N., Thornsberry C. Cefotaxime a review of in vitro antimicrobial properties and spectrum of activity . Rev Infect Dis. 4:(suppl):1992;S300-S315.
18. Kresken M., Hafner D., Mittermayer H., Verbist L., Bergogne-Berezin E., Giamarellou H., Esposito S., van Klingeren B., Kayser F.H., Reeves D.S. Prevalence of fluoroquinolone resistance in Europe. Study group "bacterial resistance" of the Paul-Ehrlich Society for chemotherapy e. V. Infection. 22:(suppl 2):1994;S90-S98.
19. Livermore D.M. Clinical significance of β-lactamase induction and stable derepression on gram-negative rods. Eur J Clin Microbiol. 6:1987;439-445.
20. Livermore D.M. β-lactamases in laboratory and clinical resistance. Clin Microbiol Rev. 8:1995;557-584.
21. Minami S., Yotsugi A., Inoue H., Mitsuhashi S. Induction of β-lactamase by various β-lactam antimicrobials in Enterobacter cloacae. Antimicrob Agents Chemother. 18:1980;382-385.
22. Reeves D.S., Bywater M.J., Holt H.A. The activity of cefpirome and ten other antibacterial agents against 2858 clinical isolates collected from 20 centres. J Antimicrob Chemother. 31:1993;345-362.
23. Richmond M.H., Sykes R.B. The β-lactamases of Gram-negative bacteria and their possible physiological role. Adv Microbiol Physiol. 9:1973;31-88.
24. Sader H.S., Jones R.N. In vitro antimicrobial activity of cefpirome against ceftazidime-resistant isolates from two multicenter studies. Eur J Clin Microbiol Infect Dis. 13:1994;675-679.
25. Sanders C.C., Bradford P.A., Ehrhardt A.F., Bush K., Young K.D., Henderson T.A., Sanders W.E. Jr. Penicillin-binding proteins and induction of AmpC β-lactamase. Antimicrob Agents Chemother. 41:1997;2013-2015.
26. Sanders C.C., Sanders W.E. Jr. Microbial resistance to newer generation β-lactam antimicrobials Clinical and laboratory implications . J Infect Dis. 151:1985;399-406.
27. Stapleton P., Shannon K., Phillips I. The ability of β-lactam antimicrobials to select mutants with derepressed β-lactamase synthesis from Citrobacter freundii. J Antimicrob Chemother. 36:1995;483-496.
28. Sykes R.B., Matthew M. The β-lactamases of Gram-negative bacteria and their role in resistance to β-lactam antibiotics. J Antimicrob Chemother. 2:1976;115-157.